ArticleVaccine2025

Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel.

Margarita Mishina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.